134 related articles for article (PubMed ID: 24419295)
1. Simeprevir (Olysio) for chronic hepatitis C.
Med Lett Drugs Ther; 2014 Jan; 56(1433):1-3. PubMed ID: 24419295
[No Abstract] [Full Text] [Related]
2. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
[No Abstract] [Full Text] [Related]
3. [New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed].
Lennerstrand J; Bondeson K; Bergqvist A; Blomberg J; Oberg B
Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3254-6, 3258, 3260. PubMed ID: 20101837
[No Abstract] [Full Text] [Related]
4. Simeprevir: a macrocyclic HCV protease inhibitor.
Talwani R; Heil EL; Gilliam BL; Temesgen Z
Drugs Today (Barc); 2013 Dec; 49(12):769-79. PubMed ID: 24524095
[TBL] [Abstract][Full Text] [Related]
5. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
Ollendorf DA; Tice JA; Pearson SD
JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
[No Abstract] [Full Text] [Related]
6. Special report: cost-effectiveness studies of new hepatitis C treatments.
Mark DH;
Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
[No Abstract] [Full Text] [Related]
7. Simeprevir: first global approval.
Vaidya A; Perry CM
Drugs; 2013 Dec; 73(18):2093-106. PubMed ID: 24293133
[TBL] [Abstract][Full Text] [Related]
8. [Galexos: an advance against hepatitis C].
Sabourin G
Perspect Infirm; 2014; 11(4):57. PubMed ID: 25269245
[No Abstract] [Full Text] [Related]
9. Simeprevir for hepatitis C virus.
Hutcheson S; Klibanov OM
Nurse Pract; 2014 Sep; 39(9):10-2. PubMed ID: 25140845
[No Abstract] [Full Text] [Related]
10. Treatment of chronic hepatitis C virus infection in the near future.
Cheinquer H
Ann Hepatol; 2013; 12(6):854-9. PubMed ID: 24114813
[No Abstract] [Full Text] [Related]
11. Simeprevir approved for hepatitis C virus infection.
Traynor K
Am J Health Syst Pharm; 2014 Jan; 71(1):6. PubMed ID: 24352170
[No Abstract] [Full Text] [Related]
12. The high price of the new hepatitis C virus drugs.
Steinbrook R; Redberg RF
JAMA Intern Med; 2014 Jul; 174(7):1172. PubMed ID: 24798183
[No Abstract] [Full Text] [Related]
13. New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.
Hussar DA; Jin ZJ
J Am Pharm Assoc (2003); 2014; 54(2):202-7. PubMed ID: 24632934
[No Abstract] [Full Text] [Related]
14. Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.
Berden FA; Kievit W; Baak LC; Bakker CM; Beuers U; Boucher CA; Brouwer JT; Burger DM; van Erpecum KJ; van Hoek B; Hoepelman AI; Honkoop P; Kerbert-Dreteler MJ; de Knegt RJ; Koek GH; van Nieuwkerk CM; van Soest H; Tan AC; Vrolijk JM; Drenth JP
Neth J Med; 2014 Oct; 72(8):388-400. PubMed ID: 25387551
[TBL] [Abstract][Full Text] [Related]
15. Patients eligible for treatment with simeprevir in a French center.
Morel V; Duverlie G; Brochot E
J Clin Virol; 2014 Sep; 61(1):149-51. PubMed ID: 25027573
[TBL] [Abstract][Full Text] [Related]
16. [A new era in therapy of chronic hepatitis C].
Füessl HS
MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
[No Abstract] [Full Text] [Related]
17. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
[No Abstract] [Full Text] [Related]
18. Chronic viral hepatitis. Treatment progress, hopes for cures.
Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
[No Abstract] [Full Text] [Related]
19. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection.
Patel N; Nasiri M; Koroglu A; Amin R; McGuey L; McNutt LA; Roman M; Miller C
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):189-97. PubMed ID: 25432275
[TBL] [Abstract][Full Text] [Related]
20. [New combination therapy increases chances of recovery].
Jäger-Becker D
MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
